Displaying 1 - 6 of 6
Addressing the global Pegasys® shortage
Updated:
Following Health Canada’s decision to grant ropeginterferon (BESREMi®) exceptional importation status, some of the provinces and private insurance plans have been starting to cover BESREMi® treatment. Work is continuing in the provinces where there is not yet coverage.
Advocacy, Partners, Myeloproliferative neoplasms
Polycythemia Vera (PV)
Updated:
Learn more about polycythemia vera (PV) and the resources we have available.
Myeloproliferative neoplasms
Myeloproliferative neoplasms
Updated:
Learn more about myeloproliferative neoplasms and the resources we have available.
Myeloproliferative neoplasms
Essential thrombocythemia (ET)
Updated:
Learn more about essential thrombocythemia (ET) and the resources we have available.
Myeloproliferative neoplasms
Myelofibrosis (MF)
Updated:
Learn more about myelofibrosis (MF) and the resources we have available.
Myeloproliferative neoplasms
Chronic Neutrophilic Leukemia (CNL)
Updated:
Learn more about chronic neutrophilic leukemia (CNL) and the resources we have available.
Myeloproliferative neoplasms